RYCVX | UOPSX | RYCVX / UOPSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 27 years | - |
Gain YTD | 26.499 | 33.796 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 15000 | 17% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 64.7M | 1.01B | 6% |
Annual Yield % from dividends | 0.37 | 0.00 | - |
Returns for 1 year | 46.27 | 49.59 | 93% |
Returns for 3 years | 18.66 | -6.02 | -310% |
Returns for 5 years | 69.53 | 113.92 | 61% |
Returns for 10 years | 265.45 | 497.14 | 53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AIVIX | 13.94 | -0.03 | -0.21% |
AB International Value I | |||
RMEBX | 58.52 | -0.52 | -0.88% |
American Funds American Mutual R2E | |||
BABDX | 12.84 | -0.16 | -1.23% |
BlackRock Global Dividend Inv A | |||
GQIRX | 47.45 | -0.73 | -1.52% |
Goldman Sachs US Tax-Managed Eq Inv | |||
BRWUX | 25.69 | -0.63 | -2.39% |
MFS Blended Research Growth Eq R4 |